Cynata and apceth in deal to develop stem cell-based therapeutics – The Pharma Letter (registration)
|
Cynata and apceth in deal to develop stem cell-based therapeutics
The Pharma Letter (registration) Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) has entered into a worldwide license option agreement with German biopharma firm apceth. The agreement will combine Cynata's Cymerus technology with genetic … |
